ISATUXIMAB-IRFC

54 reported adverse events

Drug classes: CD38-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking ISATUXIMAB-IRFC:

# Side effect Count
0 NEUTROPENIA 9
1 URINARY TRACT INFECTION 6
2 NEUTROPHIL COUNT DECREASED 5
3 UPPER RESPIRATORY TRACT INFECTION 4
4 ABDOMINAL PAIN 3
5 DRUG HYPERSENSITIVITY 3
6 HEADACHE 3
7 INFUSION RELATED REACTION 3
8 MALAISE 3
9 OFF LABEL USE 3
See all common reactions for ISATUXIMAB-IRFC

ISATUXIMAB-IRFC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYELOCYTE PERCENTAGE DECREASED 1 0.3333
1 PULMONARY VENOUS HYPERTENSION 1 0.0769
2 MYELOCYTE COUNT DECREASED 1 0.0714
3 CANCER SCREENING ABNORMAL 1 0.0526
4 PSEUDOMONAS PERITONITIS 1 0.0278
5 PLASMA CELLS INCREASED 1 0.0135
6 PATERNAL DRUGS AFFECTING FOETUS 1 0.0027
7 MARROW HYPERPLASIA 1 0.0015
8 OESOPHAGITIS ULCERATIVE 1 0.0015
9 PREGNANCY OF PARTNER 1 0.0014
See all enriched reactions for ISATUXIMAB-IRFC